Filing Details
- Accession Number:
- 0001855763-23-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-27 10:52:10
- Reporting Period:
- 2023-02-09
- Accepted Time:
- 2023-02-27 10:52:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1348362 | Lexaria Bioscience Corp. | LEXX | Pharmaceutical Preparations (2834) | 202000871 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1705278 | C. Catherine Turkel | 19900 Macarthur Blvd., Suite 550 Irvine CA 92612 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2023-02-09 | 1,500 | $2.84 | 1,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Options | $3.04 | 2022-09-02 | 2027-09-02 | 3,400 | 3,400 | Direct |
| Common Shares | Stock Options | $1.96 | 2022-10-12 | 2027-10-12 | 1,600 | 5,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2027-09-02 | 3,400 | 3,400 | Direct |
| 2027-10-12 | 1,600 | 5,000 | Direct |
Billionaire Hedge Funds
